4.6 Review

Development and Implementation of Electronic Health Record-Integrated Model-Informed Clinical Decision Support Tools for the Precision Dosing of Drugs

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 107, 期 1, 页码 129-135

出版社

WILEY
DOI: 10.1002/cpt.1679

关键词

-

资金

  1. Gerber Foundation
  2. Ohio Development Services Agency
  3. Ohio Third Frontier [TECG20170361]
  4. Cincinnati Children's Hospital Medical Center's Innovation Fund
  5. State of Ohio

向作者/读者索取更多资源

Imagine it is 2030, and the drug label is in the cloud, is interactive, and can provide model-informed precision dosing support based on an individual's genomic and physiologic makeup that is uploaded via a user-friendly interface. Precision medicine has vastly improved our ability to provide tailored therapeutics, and groundbreaking advances in noninvasive systems have generated smart wearable devices that can follow our physiologic state and drug exposure in real time. One device consists of a microfluidic drug biosensor with a transmitter attached to the skin and a mobile app that displays concentration values and trends while issuing alerts and providing suggestions on dose changes when out of range. This sounds compelling, but why has model-informed precision dosing not yet become common clinical reality in 2020?

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据